1st Edition
Polypeptide Innovations Advancements in Delivery and Targeting for Precision Medicine
Preface
List of Contributors
About The Editor
Chapter 1: Introduction to Polypeptides: The Definitions, Structures, And Ways Of Synthesis
Ahmed AH Abdellatif, Ehab Saad Elkhayat, Mahmoud A. H. Mostafa
Chapter 2: Polypeptides Delivery: Nanoformulations and Applications
Ahmed AH Abdellatif, Waleed Mohammad Altowayan
Chapter 3: Design and Characterization of Polypeptide Nanocarriers
Ahmed AH Abdellatif, Mahmoud A. H. Mostafa, Muhmamad Liaquat Raza
Chapter 4: Advances in Multilayer Nanoarchitectures and Activatable Protein Nanoparticles for Precision Medicine
Hesham M. Tawfeek, Yasser A. Hassan, Mahmoud M.A. Elsayed, Jelan A. Abdel -Aleem
Chapter 5: Nanocarrier-Based Approaches for Intracellular Protein Transport in Therapeutic Applications
Mahmoud Darweesh, Saeed Mohammadi, Moosa Al-Hamadani, Mahmoud Moustafa, Ahmed Al-Harrasi
Chapter 6: Novel Approaches and Advances in Therapeutic Glycoprotein Delivery and Applications
Mahmoud A. H. Mostafa, Hamad Alrbyawi, Ahmed AH Abdellatif, Mahmoud Darweesh
Chapter 7: Mechanisms of Polypeptide Stability and Degradation
Muhammad Liaquat Raza, Liaqat Ali, Syed Nawazish Ali, Ahmed AH Abdellatif
Chapter 8: Clinical Application of Peptides in Disease Management
Ehab Saad Elkhayat, Ahmed AH Abdellatif, Mahmoud A. H. Mostafa
Chapter 9: Regulatory Challenges and Strategies in Polypeptide Therapeutics
Muhammad Liaquat Raza
Chapter 10: Personalized Medicine: Customizing Polypeptide Formulations\
Subia Jamil, Muhammad Liaquat Raza
Chapter 11: Case Studies in Successful Polypeptide Therapeutics
Nahla Sameh Tolba, Amani E. Alharbi, Safaa Y. Eid, Ahmed AH Abdellatif
Chapter 12: Future Directions in Polypeptide Research and Development
Muhammad Liaquat Raza, Asra Faiz
Chapter 13: Involvement of Polypeptides in Personalized Medicine: The Future Endorsement and Challenges
Ahmed AH Abdellatif
Index
Biography
Ahmed AH Abdellatif is a highly experienced expert in the field of Pharmaceutics and Pharmaceutical Technology, with over 22 years of experience in basic research and new dosage form formulation. He holds a Ph.D. in Pharmaceutical Technology from the University of Regensburg in Germany, and during his time there, he worked at the Institute of Chemistry and Pharmacy. Abdellatif has extensive knowledge of the synthesis of different types of nanoparticles, including metal and polymeric nanoparticles, coupled with his experience in the characterization of nanoparticles, chemical synthesis, cell biology, and biotechnological methods, make him an ideal candidate for anyone seeking to develop innovative solutions with nanoparticles that can revolutionize the field of nanotechnology. Abdellatif' has experience in developing nanoparticles and that each step of the process, from synthesis to characterization. This level of meticulousness is evident in his work, as he has authored or co-authored more than 100 publications, demonstrating a deep understanding of the latest advancements in formulation of new dosage, nanobiotechnology, chemical synthesis, cell biology, and receptor targeting. Currently, Abdellatif works as a Professor in the Department of Pharmaceutics at the College of Pharmacy at Qassim University. He continues to develop his skills and knowledge in the field and is excited to bring his expertise to any team seeking to develop new and innovative solutions with nanoparticles. Throughout his career, Abdellatif has demonstrated a passion for educating future generations of scientists and researchers. His work has focused on developing innovative solutions to common problems in the field, such as improving the bioavailability of drugs and enhancing drug delivery systems. His research has also explored the potential of nanoparticle-based therapeutics in treating a variety of diseases, including cancer and infectious diseases. Abdellatif's work in the field of nanotechnology has the potential to revolutionize the way we approach drug delivery and treatment. By developing innovative solutions with nanoparticles, he is helping to pave the way for safer, more effective therapies that can improve patient outcomes and save lives.
